Document Detail


Cellular energetic status supervises the synthesis of bis-diphosphoinositol tetrakisphosphate independently of AMP-activated protein kinase.
MedLine Citation:
PMID:  18460607     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cells aggressively defend adenosine nucleotide homeostasis; intracellular biosensors detect variations in energetic status and communicate with other cellular networks to initiate adaptive responses. Here, we demonstrate some new elements of this communication process, and we show that this networking is compromised by off-target, bioenergetic effects of some popular pharmacological tools. Treatment of cells with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), so as to simulate elevated AMP levels, reduced the synthesis of bis-diphosphoinositol tetrakisphosphate ([PP](2)-InsP(4)), an intracellular signal that phosphorylates proteins in a kinase-independent reaction. This was a selective effect; levels of other inositol phosphates were unaffected by AICAR. By genetically manipulating cellular AMP-activated protein kinase activity, we showed that it did not mediate these effects of AICAR. Instead, we conclude that the simulation of deteriorating adenosine nucleotide balance itself inhibited [PP](2)-InsP(4) synthesis. This conclusion is consistent with our demonstrating that oligomycin elevated cellular [AMP] and selectively inhibited [PP](2)-InsP(4) synthesis without affecting other inositol phosphates. In addition, we report that the shortterm increases in [PP](2)-InsP(4) levels normally seen during hyperosmotic stress were attenuated by 2-(2-chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluoro-benzamide (PD184352). The latter is typically considered an exquisitely specific mitogen-activated protein kinase kinase (MEK) inhibitor, but small interfering RNA against MEK or extracellular signal-regulated kinase revealed that this mitogen-activated protein kinase pathway was not involved. Instead, we demonstrate that [PP](2)-InsP(4) synthesis was inhibited by PD184352 through its nonspecific effects on cellular energy balance. Two other MEK inhibitors, 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) and 2'-amino-3'-methoxyflavone (PD98059), had similar off-target effects. We conclude that the levels and hence the signaling strength of [PP](2)-InsP(4) is supervised by cellular adenosine nucleotide balance, signifying a new link between signaling and bioenergetic networks.
Authors:
Kuicheon Choi; Elahe Mollapour; Jae H Choi; Stephen B Shears
Related Documents :
9696987 - Malonyl-coa--regulator of fatty acid oxidation in muscle during exercise.
8917457 - Cloning and characterization of cdna for adenosine kinase from mammalian (chinese hamst...
12444247 - Amp kinase is required for mitochondrial biogenesis in skeletal muscle in response to c...
16236247 - Genistein, egcg, and capsaicin inhibit adipocyte differentiation process via activating...
21357687 - Identification of an interaction between the tpalpha and tpbeta isoforms of the human t...
23241357 - C-jun n-terminal kinase activation contributes to reduced connexin43 and development of...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Intramural     Date:  2008-05-06
Journal Detail:
Title:  Molecular pharmacology     Volume:  74     ISSN:  1521-0111     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-07-23     Completed Date:  2008-08-22     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  527-36     Citation Subset:  IM    
Affiliation:
Inositide Signaling Group, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AMP-Activated Protein Kinases
Animals
Cells, Cultured
Energy Metabolism / drug effects,  physiology*
Humans
Inositol Phosphates / biosynthesis*,  genetics
MAP Kinase Signaling System / drug effects,  physiology*
Male
Multienzyme Complexes / metabolism*,  physiology
Myocytes, Smooth Muscle / drug effects,  enzymology,  metabolism*
Protein Kinase Inhibitors / pharmacology
Protein-Serine-Threonine Kinases / metabolism*,  physiology
Rats
Grant Support
ID/Acronym/Agency:
Z01 ES080046-19/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Inositol Phosphates; 0/Multienzyme Complexes; 0/Protein Kinase Inhibitors; 0/inositol 1,2,3,4-tetraphosphate 5,6-dipyrophosphate; EC 2.7.11.1/AMP-Activated Protein Kinases; EC 2.7.11.1/Protein-Serine-Threonine Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of a xylogalacturonan xylosyltransferase involved in pectin biosynthesis in Arabidops...
Next Document:  A heat acclimation protocol for team sports.